Disclosed is a Chinese pharmaceutical composition for treating cardiovascular and cerebrovascular diseases, wherein the raw materials of the pharmaceutical composition comprise the following constituents (by weight ratio): notoginseng 0.5-200, kudzu vine root 0.5-200, musk rat must 0.00001-10. The composition can be made into dosage forms of tablets, capsules, granules, pills, powders, mixture, preferably drop pills. The invention also discloses the process for making pharmaceutical preparation from the pharmaceutical composition.